Advanced diagnostic capabilities for cough assessment utilizing the neural network model «CoughScan»: findings from a prospective, comparative observational study
Open Access
- 18 August 2026
- journal article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (8) , 478-485
Abstract
Background. Identifying the character, frequency, and intensity of cough is crucial in clinical practice, aiding in differential diagnosis, influencing treatment choices. «CoughScan» is a software with an embedded neural network model designed to assess cough frequency in real-time for diagnostic and monitoring purposes. Aim. To obtain additional data on the efficacy and safety of Rengalin® in the treatment of cough in adults with acute respiratory viral infections (ARVI) using both traditional and new intelligent technologies. Materials and methods. An observational study was conducted involving 60 patients with ARVI, receiving Rengalin® for cough management. Outpatient patients were divided into 2 groups: the main group (n=40) received Rengalin® for 7 days, while the control group (n=20) received no cough medication. The severity of symptoms of ARVI and cough was assessed with Cough severity scale (CSS), «CoughScan», Bronchitis Severity Scale (BSS). Results. The cough severity score on CSS decreased by 2.9 points in the Rengalin® group and by 1.5 points in the control group (p=0.0004). The average BSS score reduced by 1.3 units with Rengalin® and by 0.2 units in controls (p=0.0001). The mean duration of cough during treatment was 5.7±0.2 days versus 7.2±0.4 days without treatment (p=0.0178). Monitoring of daily cough intensity with «CoughScan» also showed a statistically significant advantage in the Rengalin® group (p0.0001). A non-inferiority test based on the area under the curve (AUC) over 7 days indicated comparable results between «CoughScan» and the CSS, with differences within 10%. Conclusion. «CoughScan» is a convenient and reliable tool for assessing cough dynamics in outpatient settings. Its data are comparable to the Cough severity scale regarding treatment efficacy, with antitussive activity of Rengalin® evident from the early days of therapy.Keywords
This publication has 18 references indexed in Scilit:
- The role of bradykinin as a pathogenetic target and prospects for pharmacological correction of cough associated with angiotensin-converting enzyme inhibitors: Results of an open-ended prospective observational programTherapy, 2025
- Cough duration, energy and sound frequency in COVID-19 patients: the spectral analysis resultsBMC Pulmonary Medicine, 2025
- Cough diagnosis: from origins to modern times (review of literature)Journal of Respiratory Medicine, 2025
- Cough monitoring systems in adults with chronic respiratory diseases: a systematic reviewEuropean Respiratory Review, 2025
- Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19PULMONOLOGIYA, 2024
- Randomised trial of the P2X3receptor antagonist sivopixant for refractory chronic coughEuropean Respiratory Journal, 2021
- Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleepAsthma Research and Practice, 2020
- How to count coughs? Counting by ear, the effect of visual data and the evaluation of an automated cough monitorRespiratory Medicine, 2014
- An Automated System for 24-h Monitoring of Cough Frequency: The Leicester Cough MonitorIEEE Transactions on Biomedical Engineering, 2007
- Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring?Thorax, 2007